RxDoctor Payments Data

Katelyn Carroll

Nurse Practitioner · Morgantown, WVNPI 1750851853

Payments from drug & device makers

$1,954in general payments, 2019–2025

Across 104 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$921
  • Johnson & Johnson$240
  • Braintree Laboratories, Inc.$181
  • Boston Scientific$144
  • Sanofi$94
  • Bristol Myers Squibb$85
  • plus $289 from 9 others

What the payments were for

  • Food & beverage$1,954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,954 in reported general payments places this provider in the 85th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Medicare billing

Part B allowed, 2024
$20,459
Medicare patients
140
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase36$166,989
LinzessLinaclotide66$40,931
Mesalamine33$11,455
Colestipol Hcl50$4,351
Mesalamine ErMesalamine20$3,500
Dexlansoprazole DrDexlansoprazole14$2,715
Budesonide DrBudesonide27$2,508
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates31$2,110
Omeprazole114$1,964
Sucralfate40$1,625
Pantoprazole Sodium152$1,235
Dicyclomine Hcl55$844
Famotidine70$687
Esomeprazole Magnesium17$682
Sulfasalazine16$626

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$921$207,920102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 649 nurse practitioner providers in West Virginia.

Other nurse practitioner in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →